|
|
La lettre / Jeudi 28 mars 2024
|
|
|
|
|
|
|
|
|
|
|
|
Friday 29 March at 11:30 // The dark side of dopamine: the paradoxical influences of dopamine on striatal motor functions
|
|
|
|
|
|
|
|
Wednesday 3rd April at 11:30 // Improving cognitions: Insights from a decade of Fmθ neurofeedback research
|
|
|
|
|
|
|
|
Félicitations à David Perrais, Naoya Takahashi et Pierre Trifilieff
|
|
|
|
|
|
|
|
Date limite de candidature : jeudi 25 avril à 11h00.
|
|
|
|
|
|
|
|
|
|
|
|
3 publications impliquant des chercheuses et chercheurs bordelais sont parmi les 22 highlights
|
|
|
|
|
|
|
|
|
|
|
|
3-19 April // Venue: CGFB // Open to everyone.
|
|
|
|
|
|
|
|
Abstract submission until April 1st.
|
|
|
|
|
|
|
|
Mind the date! Registration before March 31st, 2024!
|
|
|
|
|
|
|
|
AGENDA
|
The dark side of dopamine: the paradoxical influences of dopamine on striatal motor functions
// Venue: Centre Broca
Invited by Jérôme Baufreton (IMN)
|
Bilateral vestibular loss and space flight: common consequences? // Flying to the moon, a never ending story or a fleeting time ? How bilateral vestibular deafferentation affects time estimation in rats.
// Venue: BBS
Invited by Ellemarije Altena and Etienne Guillaud (INCIA)
|
Improving cognitions: Insights from a decade of Fmθ neurofeedback research
// Venue: Centre Broca
Invited by Elise Grevet (INCIA)
|
Lectures are open to everyone.
// Venue: CGFB
|
Please register no later than April 1
// Venue: CGFB
|
|
// Venue: Centre Broca Nouvelle-Aquitaine
|
|
|
|
Pour tous
|
|
|
|
|
|
|
|
|
|
Dur to technical issues, our database could not be updated. Thank for you understanding.
|
|
|
|
|
|
|
|
|
|
New calls
|
Financer des évaluations cliniques post marquage CE
|
|
Several types of grants with several deadlines
|
|
fostering innovative research in collaboration with HD clinics to better understand the biology of Huntington’s disease as it occurs in humans
|
|
thèses pluridisciplinaires intégrant des aspects mathématiques, informatiques et biomédicaux
|
|
From basic science that can change the way we think about MeCP2 to clinical research that directly impacts potential treatment
|
|
4 prizes : Outstanding Innovation in Neurodegenerative Research / Innovative Early-Career Scientist / Milestone Prize for Advances in Tauopathy Research / Breakthrough Prize for Effective Treatments in PSP
|
|
Association Huntington France
|
|
Les thèmes de recherche concernent l’épidémiologie, la physiopathologie, le traitement des pathologies neurovasculaires.
|
|
discovery and development of novel disease progression and stratification biomarkers using any modality.
|
|
tout projet de recherche relatif à la maladie Willis Ekbom, plus connue sous le nom de syndrome des jambes sans repos.
|
|
Expire le 30 septembre 2024
|
|
|
|
|
|
Ending soon
|
Parmi les domaines : la psychologie et la neurobiologie
|
|
Société Française de Recherche et Médecine du Sommeil : Projet de Master 2 / Année de thèse ou de post-doc / Projet multicentrique SFRMS / Allocation doctorale
|
|
Intended to support the creation of a national network to develop an innovative research project
|
|
Soutenir la lutte contre la douleur
|
|
En partenariat et avec le soutien de la Fondation ARSEP
|
|
Emergence – New network and Annual call
|
|
Short term research visits of young ISN members in the labs of established ISN members
|
|
seeks to foster international scientific collaboration and development of human resources
|
|
The aim of this new fellowship is to give medical students the possibility and experience to gain insight in neurology
|
|
Pour une jeune chercheuse ou un jeune chercheur en psychologie
|
|
A un(e) jeune chercheur(e) dont les résultats de thèse peuvent faire progresser les connaissances sur la physiopathologie, le diagnostic ou la prise en charge thérapeutique des Neuropathies Optiques Héréditaires.
|
|
Short term research visits of young ISN members
|
|
Federation of European Biochemical Societies
|
|
The research plan should entail patient-oriented research in PD or other parkinsonian disorders, and address unmet needs of people living with these conditions.
|
|
Funds for trainee authors of reviews to present at a Neurochemistry or Neuroscience meeting.
|
|
Supporting young group leaders in Europe and beyond
|
|
offer funds to help enable established investigators
|
|
AES funding may be used for speakers’ transportation and lodging, participation by junior investigators and trainees, the publication of proceedings, and other direct costs,
|
|
Destinés à récompenser de jeunes médecins et/ou scientifiques pour leurs contributions à la recherche sur la maladie d’Alzheimer et les maladies apparentées.
|
|
Permettre à de jeunes chercheurs de formation scientifique ou médicale de poursuivre leurs travaux de recherche sur la maladie d’Alzheimer et les maladies apparentée
|
|
recognizes individuals dedicated to women’s advancement in neuroscience through mentorship.
|
|
recognizes a early career neuroscientist’s outstanding PhD thesis advancing understanding of molecular, genetic, or cellular mechanisms underlying higher brain function and cognition
|
|
Behavioral neuroscience is defined for these purposes as neuroscience research involving behavioral variables or oriented toward the solution of behavioral problems.
|
|
Nominations must be made or endorsed by an SfN member.
|
|
drug addiction / neuropharmacology (or a related area) / neuroscience / women in neuroscience
|
|
|
|
|
|
|
|
|
|
